The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

SPINAL FLUID CHANGES IN PATIENTS TREATED WITH ATARACTIC DRUGS

Published Online:https://doi.org/10.1176/ajp.116.6.545

In a series of 25 patients on ataractic therapy and 25 other mental patients as controls, there was no essential difference in the incidence of increased protein or abnormal gold curves. The high incidence of abnormal findings in both of these groups, however, points to the possibility that these abnormal findings are unspecific and may also be found to a certain extent within the general healthy population. This study does not support the assumption that increased spinal fluid protein and abnormal gold curves are the result of ataractic therapy.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.